BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15446572)

  • 1. [Orotate phosphoribosyl transferase in bladder cancer].
    Furuse H; Hirano Y; Harada M; Mugiya S; Ushiyama T; Suzuki K; Ozono S
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1431-3. PubMed ID: 15446572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma.
    Mizutani Y; Wada H; Fukushima M; Yoshida O; Nakanishi H; Li YN; Miki T
    Cancer; 2004 Feb; 100(4):723-31. PubMed ID: 14770427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of 5-fluorouracil-related enzyme activities in predicting sensitivity to 5-fluorouracil in bladder carcinoma.
    Furuse H; Hirano Y; Harada M; Ming LH; Aoki T; Kurita Y; Mugiya S; Ushiyama T; Ozono S
    Anticancer Res; 2009 Apr; 29(4):1001-8. PubMed ID: 19414338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU.
    Isshi K; Sakuyama T; Gen T; Nakamura Y; Kuroda T; Katuyama T; Maekawa Y
    Int J Clin Oncol; 2002 Dec; 7(6):335-42. PubMed ID: 12494248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Cancer Chemother Pharmacol; 2003 Jan; 51(1):29-35. PubMed ID: 12497203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil on gastric cancer cell lines.
    Taomoto J; Yoshida K; Wada Y; Tanabe K; Konishi K; Tahara H; Fukushima M
    Oncology; 2006; 70(6):458-64. PubMed ID: 17237621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Kihara A; Okano M
    Gan To Kagaku Ryoho; 2001 May; 28(5):661-7. PubMed ID: 11383215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between enzymatic activity and gene expression of orotate phosphoribosyl transferase (OPRT) in colorectal cancer].
    Takumi O; Michiharu S; Kazuhiko N; Hajime N; Tsuyoshi O; Sumito S; Hirohiko K; Nagaoka I
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2515-9. PubMed ID: 12506474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma.
    Fujii R; Seshimo A; Kameoka S
    Int J Clin Oncol; 2003 Apr; 8(2):72-8. PubMed ID: 12720098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of orotate phosphoribosyl transferase activity in resectable colorectal cancers treated by 5-fluorouracil-based adjuvant chemotherapy.
    Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsuruoka Y; Takahashi Y; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
    J Surg Oncol; 2006 Jul; 94(1):45-50. PubMed ID: 16788943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orotate phosphoribosyl transferase mRNA expression in oral squamous cell carcinoma and its relationship with the dihydropyrimidine dehydrogenase expression and the clinical effect of 5-fluorouracil.
    Yoshitomi I; Kawasaki G; Yanamoto S; Mizuno A
    Oral Oncol; 2006 Oct; 42(9):880-7. PubMed ID: 16757204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Choice of chemotherapeutic drugs for colorectal cancers by DPD and OPRT activities in cancer tissues].
    Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1053-6. PubMed ID: 15272584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of enzyme-linked immunosorbent assay for quantification of orotate phosphoribosyltransferase in gastric carcinoma].
    Sakurai Y; Sakamoto K; Sugimoto Y; Yoshida I; Masui T; Tonomura S; Inaba K; Shoji M; Nakamura Y; Uyama I; Komori Y; Ochiai M; Matsuura S; Tanaka H; Oka T; Fukushima M
    Gan To Kagaku Ryoho; 2005 Jul; 32(7):1017-22. PubMed ID: 16044965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of orotate phosphoribosyl transferase activity as a predictor of lymph node metastasis in gastric cancer.
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Okada T; Ouchi M; Yamada M; Kitajima M; Tsuruoka Y; Takahashi Y; Futagawa S
    Oncol Rep; 2005 Oct; 14(4):987-92. PubMed ID: 16142362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of orotate phosphoribosyl transferase in hormone-refractory prostate cancer.
    Tanaka T; Kawashima H; Matsumura K; Yamashita-Hosono T; Yoshimura R; Kuratsukuri K; Harimoto K; Nakatani T
    Oncol Rep; 2009 Jan; 21(1):33-7. PubMed ID: 19082440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and pathophysiologic features of orotate phosphoribosyl transferase activity (OPRT) in gastric carcinoma].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Kihara A; Okano M
    Gan To Kagaku Ryoho; 2001 Mar; 28(3):345-50. PubMed ID: 11265402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Komiyama H; Okano M
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):413-20. PubMed ID: 11915731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orotate phosphoribosyltransferase expression level in tumors is a potential determinant of the efficacy of 5-fluorouracil.
    Sakamoto E; Nagase H; Kobunai T; Oie S; Oka T; Fukushima M; Oka T
    Biochem Biophys Res Commun; 2007 Nov; 363(1):216-22. PubMed ID: 17854773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.